ContributorsPublishersAdvertisers

Cancer patients with poor antibody response to COVID-19 vaccines also lack secondary immune response

MedicalXpress
 2021-10-19

Cover picture for the articlePatients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response from a different part of the immune system, known as T cells. Their discovery was published in a research letter in...

medicalxpress.com

Comments / 0

Comments / 0